Northernmost
Cambridge, United States· Est.
Northernmost builds a portable, continuous‑perfusional pump to keep donor kidneys viable from donor to recipient.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $2.7M
AI Company Overview
Northernmost builds a portable, continuous‑perfusional pump to keep donor kidneys viable from donor to recipient.
Kidney Transplantation
Technology Platform
A portable, battery‑powered perfusion system that continuously oxygenates and circulates preservation solution through donor kidneys, maintaining physiologic temperature and metabolism.
Opportunities
A portable perfusion device can expand organ preservation to smaller centers, increase donor organ utilization, and open pathways to multi‑organ applications.
Risk Factors
Regulatory clearance timelines, clinical validation of superiority over cold storage, and competition from established perfusion platforms could delay market entry.
Competitive Landscape
Key competitors include OrganOx (Metra) and TransMedics; Northernmost differentiates itself through a lightweight, low‑cost design aimed at broader adoption.